CBHB
0339
SET
0337
COLFORM
0341
4
NORTHERN
0340
5
TECHSTORE
0343
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -728.62%-43.51M | -64.75%4.81M | -538.44%-18.97M | -1,548.93%-17.59M | -136.77%-11.76M | -7.42%6.92M | 312.95%13.64M | -110.56%-2.97M | -72.65%1.21M | -534.09%-4.97M |
Net profit before non-cash adjustment | -81.42%13.59M | -71.42%1.82M | -95.54%2.71M | 6.40%3.81M | 113.69%5.25M | 1,046.46%73.13M | 96.37%6.38M | 20,895.21%60.72M | 131.13%3.58M | 203.46%2.46M |
Total adjustment of non-cash items | 109.62%4.95M | -25.02%4.44M | 100.71%431K | -108.21%-124K | -87.48%202K | -321.31%-51.43M | 27.70%5.92M | -3,374.34%-60.48M | -89.08%1.51M | -44.78%1.61M |
-Depreciation and amortization | -89.07%618K | -62.24%233K | -87.87%183K | -93.56%115K | -95.01%87K | -40.25%5.66M | -69.55%617K | -26.82%1.51M | -26.12%1.79M | -41.09%1.75M |
-Reversal of impairment losses recognized in profit and loss | 110.95%4.11M | 108.92%4.11M | --0 | ---- | ---- | -1,314.05%-37.5M | -1,540.77%-46.05M | --8.45M | ---- | ---- |
-Disposal profit | 97.84%-422K | ---23K | 99.56%-83K | 20.32%-302K | 92.09%-14K | -280.51%-19.51M | --0 | -7,246.90%-18.96M | -103.29%-379K | -113.25%-177K |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --16K |
-Other non-cash items | 948.68%645K | -99.76%122K | 100.64%331K | 125.00%63K | 330.00%129K | -240.74%-76K | 128,472.50%51.35M | -119,827.91%-51.48M | 300.00%28K | -31.82%30K |
Changes in working capital | -319.78%-62.04M | -207.80%-1.45M | -587.44%-22.11M | -448.98%-21.27M | -90.44%-17.21M | -83.89%-14.78M | 129.42%1.35M | -8.43%-3.22M | -284.88%-3.88M | -249.11%-9.04M |
-Change in receivables | 13.91%-46.14M | 121.28%3.51M | 40.13%-12.55M | -71.82%-8.46M | -155.38%-28.65M | -278.73%-53.6M | -167.15%-16.5M | -194.69%-20.96M | -509.91%-4.92M | -19,582.46%-11.22M |
-Change in payables | -39.81%20.77M | -45.62%6.09M | -89.67%1.86M | -330.91%-7.53M | 877.95%20.36M | 464.32%34.51M | 282.27%11.19M | 446.23%17.98M | 12.99%3.26M | 169.66%2.08M |
-Changes in other current assets | -951.21%-36.67M | -265.90%-11.05M | -4,657.92%-11.42M | -138.75%-5.29M | -8,841.18%-8.92M | --4.31M | 601.13%6.66M | -128.10%-240K | -13,123.53%-2.21M | -77.73%102K |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -298.49%-1.32M | -686.89%-480K | -434.72%-385K | -142.00%-242K | -116.33%-212K | -0.61%-331K | 38.38%-61K | 17.24%-72K | -38.89%-100K | -38.03%-98K |
Interest received (cash flow from operating activities) | ||||||||||
Tax refund paid | -8.36%-4.68M | 45.47%-945K | -64.64%-1.74M | -33.33%-852K | -28.54%-1.14M | -29.60%-4.32M | -26.96%-1.73M | 35.94%-1.06M | -102.86%-639K | -22,150.00%-890K |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 15.49%-240K | 0 | 37.21%-27K | 1.82%-54K | -736.84%-159K |
Operating cash flow | -2,535.02%-49.5M | -71.44%3.38M | -411.27%-21.09M | -4,538.00%-18.68M | -114.53%-13.11M | -42.44%2.03M | 608.31%11.85M | -29.39%-4.13M | -89.47%421K | -682.19%-6.11M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -91.32%27K | -668.63%-392K | 142.13%107K | -31.92%273K | -81.86%39K | -81.66%311K | -59.38%-51K | -201.20%-254K | -70.71%401K | 99.07%215K |
Net business purchase and sale | --0 | --0 | ---- | ---- | ---- | ---727K | --0 | ---- | ---- | ---- |
Net investment property transactions | --0 | --0 | ---- | ---- | ---- | --400K | --0 | ---- | ---- | ---- |
Interest received (cash flow from investment activities) | 50.34%657K | 155.22%342K | -66.03%53K | 135.53%179K | 16.90%83K | 40.06%437K | -22.54%134K | 231.91%156K | 16.92%76K | 162.96%71K |
Investing cash flow | 62.47%684K | -160.24%-50K | 137.65%160K | -5.24%452K | -57.34%122K | -79.03%421K | -41.13%83K | -242.62%-425K | -66.74%477K | 111.85%286K |
Financing cash flow | ||||||||||
Net issuance payments of debt | 50.11%20.43M | -38.00%8.44M | --7.15M | ---4.75M | --9.6M | --13.61M | --13.61M | --0 | --0 | --0 |
Net common stock issuance | --0 | --0 | ---- | ---- | ---- | --19.89M | --0 | ---- | ---- | ---- |
Increase or decrease of lease financing | -217.07%-390K | -273.68%-142K | -236.84%-128K | -90.63%-61K | -293.33%-59K | -925.00%-123K | -375.00%-38K | -850.00%-38K | ---32K | ---15K |
Net other fund-raising expenses | 36.28%-4.18M | 78.61%-1.4M | ---2.18M | ---300K | ---300K | -5,272.95%-6.56M | ---6.52M | ---- | ---- | ---- |
Financing cash flow | -40.86%15.86M | -2.13%6.9M | -75.61%4.84M | -15,881.25%-5.11M | 61,706.67%9.24M | 20,117.91%26.82M | 5,523.85%7.05M | 495,600.00%19.82M | ---32K | ---15K |
Net cash flow | ||||||||||
Beginning cash position | 157.89%47.82M | -83.95%4.63M | 52.75%20.72M | 246.98%44.07M | 157.89%47.82M | 41.15%18.54M | 38.89%28.84M | -42.65%13.57M | -30.31%12.7M | 8.81%18.54M |
Current changes in cash | -212.57%-32.96M | -46.09%10.24M | -205.40%-16.1M | -2,795.84%-23.35M | 35.79%-3.75M | 441.58%29.28M | 1,027.32%18.98M | 627.64%15.27M | -84.05%866K | -593.00%-5.84M |
End cash Position | -68.92%14.86M | -68.92%14.86M | -83.95%4.63M | 52.75%20.72M | 246.98%44.07M | 157.89%47.82M | 157.89%47.82M | 38.89%28.84M | -42.65%13.57M | -30.31%12.7M |
Free cash flow | -3,084.67%-50.83M | -77.44%2.66M | -395.03%-21.32M | -5,247.03%-19.04M | -113.12%-13.13M | -43.92%1.7M | 895.70%11.8M | -34.80%-4.31M | -90.74%370K | -686.57%-6.16M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.